CoChat

CDK4 is an essential insulin effector in adipocytes

Open access
Lagarrigue, Sylviane, Lopez-Mejia, Isabel C., Denechaud, Pierre-Damien, Escoté, Xavier, Castillo-Armengol, Judit, Jimenez, Veronica, Chavey, Carine, Giralt, Albert, Lai, Qiuwen, Zhang, Lianjun, Martinez-Carreres, Laia, Delacuisine, Brigitte, Annicotte, Jean-Sébastien, Blanchet, Emilie, Huré, Sébastien, Abella, Anna, Tinahones, Francisco J., Vendrell, Joan, Dubus, Pierre, Bosch, Fatima, Kahn, C. Ronald, Fajas, Lluis · 2015 · Journal of Clinical Investigation
Cited by 76

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

Insulin resistance is a fundamental pathogenic factor that characterizes various metabolic disorders, including obesity and type 2 diabetes. Adipose tissue contributes to the development of obesity-related insulin resistance through increased release of fatty acids, altered adipokine secretion, and/or macrophage infiltration and cytokine release. Here, we aimed to analyze the participation of the cyclin-dependent kinase 4 (CDK4) in adipose tissue biology. We determined that white adipose tissue (WAT) from CDK4-deficient mice exhibits impaired lipogenesis and increased lipolysis. Conversely, lipolysis was decreased and lipogenesis was increased in mice expressing a mutant hyperactive form of CDK4 (CDK4(R24C)). A global kinome analysis of CDK4-deficient mice following insulin stimulation revealed that insulin signaling is impaired in these animals. We determined that insulin activates the CCND3-CDK4 complex, which in turn phosphorylates insulin receptor substrate 2 (IRS2) at serine 388, thereby creating a positive feedback loop that maintains adipocyte insulin signaling. Furthermore, we found that CCND3 expression and IRS2 serine 388 phosphorylation are increased in human obese subjects. Together, our results demonstrate that CDK4 is a major regulator of insulin signaling in WAT.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci81480This paper is marked retracted.

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Cited by

See all 76

Metadata

Authors
Lagarrigue, S., Lopez-Mejia, I. C., Denechaud, P.-D., Escoté, X., Castillo-Armengol, J., Jimenez, V., Chavey, C., Giralt, A., Lai, Q., Zhang, L., Martinez-Carreres, L., Delacuisine, B., Annicotte, J.-S., Blanchet, E., Huré, S., Abella, A., Tinahones, F. J., Vendrell, J., Dubus, P., Bosch, F., Kahn, C. R., & Fajas, L.
Venue
Journal of Clinical Investigation
Published
2015-12-14
Volume
126
Issue
1
Pages
335-348
ISSN
  • 0021-9738 (ISSN-L)
  • 1558-8238
OpenAlex
W2212034801
Cited by
76
References
17
FWCI
5.05
Type
journal article
Language
en
Status
Retracted
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: CDK4 is an essential insulin effector in adipocytes. https://app.cochat.ai/papers/10.1172/jci81480
The paper
Lagarrigue, S., Lopez-Mejia, I. C., Denechaud, P.-D., Escoté, X., Castillo-Armengol, J., Jimenez, V., Chavey, C., Giralt, A., Lai, Q., Zhang, L., Martinez-Carreres, L., Delacuisine, B., Annicotte, J.-S., Blanchet, E., Huré, S., Abella, A., Tinahones, F. J., Vendrell, J., Dubus, P., . . . Fajas, L. (2015). CDK4 is an essential insulin effector in adipocytes. Journal of Clinical Investigation. https://doi.org/10.1172/jci81480

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.